US20190343656A1 - Spinal implant system and method - Google Patents
Spinal implant system and method Download PDFInfo
- Publication number
- US20190343656A1 US20190343656A1 US16/522,946 US201916522946A US2019343656A1 US 20190343656 A1 US20190343656 A1 US 20190343656A1 US 201916522946 A US201916522946 A US 201916522946A US 2019343656 A1 US2019343656 A1 US 2019343656A1
- Authority
- US
- United States
- Prior art keywords
- spinal implant
- vertebral
- plate
- inserter
- recited
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000007943 implant Substances 0.000 title claims abstract description 126
- 238000000034 method Methods 0.000 title claims abstract description 51
- 210000000988 bone and bone Anatomy 0.000 claims description 27
- 210000001519 tissue Anatomy 0.000 claims description 20
- 230000013011 mating Effects 0.000 claims description 15
- 230000001154 acute effect Effects 0.000 claims description 4
- 230000037361 pathway Effects 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 238000001356 surgical procedure Methods 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 238000011282 treatment Methods 0.000 description 9
- -1 polyethylene terephthalate Polymers 0.000 description 8
- 239000002131 composite material Substances 0.000 description 7
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 6
- 239000001506 calcium phosphate Substances 0.000 description 6
- 239000000919 ceramic Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000004927 fusion Effects 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 229910052719 titanium Inorganic materials 0.000 description 6
- 239000010936 titanium Substances 0.000 description 6
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 6
- 239000004696 Poly ether ether ketone Substances 0.000 description 5
- 238000012937 correction Methods 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 5
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 5
- 229920002530 polyetherether ketone Polymers 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000007623 Lordosis Diseases 0.000 description 4
- 230000008468 bone growth Effects 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 3
- 235000019731 tricalcium phosphate Nutrition 0.000 description 3
- 229940078499 tricalcium phosphate Drugs 0.000 description 3
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 2
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 2
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 2
- 206010023509 Kyphosis Diseases 0.000 description 2
- 208000023178 Musculoskeletal disease Diseases 0.000 description 2
- 208000020307 Spinal disease Diseases 0.000 description 2
- 229910001069 Ti alloy Inorganic materials 0.000 description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 229940112869 bone morphogenetic protein Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 230000001045 lordotic effect Effects 0.000 description 2
- 210000004705 lumbosacral region Anatomy 0.000 description 2
- 238000002324 minimally invasive surgery Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 229920001652 poly(etherketoneketone) Polymers 0.000 description 2
- 229920006260 polyaryletherketone Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 206010039722 scoliosis Diseases 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
- 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 229910000787 Gum metal Inorganic materials 0.000 description 1
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000008558 Osteophyte Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 229920008285 Poly(ether ketone) PEK Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920000265 Polyparaphenylene Polymers 0.000 description 1
- 208000007103 Spondylolisthesis Diseases 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Inorganic materials [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 1
- 239000005313 bioactive glass Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 229960001714 calcium phosphate Drugs 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 208000018180 degenerative disc disease Diseases 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 229940077441 fluorapatite Drugs 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 230000009554 growth spurt Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 201000002972 idiopathic scoliosis Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 238000002684 laminectomy Methods 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 238000012148 non-surgical treatment Methods 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920006124 polyolefin elastomer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 108010033949 polytyrosine Proteins 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 210000000954 sacrococcygeal region Anatomy 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/4455—Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages
- A61F2/4465—Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages having a circular or kidney shaped cross-section substantially perpendicular to the axis of the spine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/4455—Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools for implanting artificial joints
- A61F2/4603—Special tools for implanting artificial joints for insertion or extraction of endoprosthetic joints or of accessories thereof
- A61F2/4611—Special tools for implanting artificial joints for insertion or extraction of endoprosthetic joints or of accessories thereof of spinal prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30112—Rounded shapes, e.g. with rounded corners
- A61F2002/30131—Rounded shapes, e.g. with rounded corners horseshoe- or crescent- or C-shaped or U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/3011—Cross-sections or two-dimensional shapes
- A61F2002/30112—Rounded shapes, e.g. with rounded corners
- A61F2002/30133—Rounded shapes, e.g. with rounded corners kidney-shaped or bean-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30471—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements connected by a hinged linkage mechanism, e.g. of the single-bar or multi-bar linkage type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30476—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements locked by an additional locking mechanism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30476—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements locked by an additional locking mechanism
- A61F2002/30505—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements locked by an additional locking mechanism spring biased
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30537—Special structural features of bone or joint prostheses not otherwise provided for adjustable
- A61F2002/30538—Special structural features of bone or joint prostheses not otherwise provided for adjustable for adjusting angular orientation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30593—Special structural features of bone or joint prostheses not otherwise provided for hollow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30836—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves knurled
Definitions
- the present disclosure generally relates to medical devices for the treatment of musculoskeletal disorders, and more particularly to a surgical system and method for treating a spine.
- Spinal pathologies and disorders such as scoliosis and other curvature abnormalities, kyphosis, degenerative disc disease, disc herniation, osteoporosis, spondylolisthesis, stenosis, tumor, and fracture may result from factors including trauma, disease and degenerative conditions caused by injury and aging.
- Spinal disorders typically result in symptoms including deformity, pain, nerve damage, and partial or complete loss of mobility.
- Non-surgical treatments such as medication, rehabilitation and exercise can be effective, however, may fail to relieve the symptoms associated with these disorders.
- Surgical treatment of these spinal disorders includes fusion, fixation, correction, discectomy, laminectomy and implantable prosthetics.
- spinal constructs such as, for example, bone fasteners, spinal rods and interbody devices can be used to provide stability to a treated region.
- interbody implants and spinal constructs can be delivered to a surgical site for fixation with bone to immobilize a joint. This disclosure describes an improvement over these prior art technologies.
- a spinal implant comprises a body including a first vertebral engaging surface and a second vertebral engaging surface.
- the first vertebral engaging surface is rotatable relative to the second vertebral engaging surface.
- FIG. 1 is a perspective view of components of one embodiment of a system in accordance with the principles of the present disclosure
- FIG. 2 is a side view of the components shown in FIG. 1 ;
- FIG. 3 is a side view of the components shown in FIG. 1 ;
- FIG. 4 is a side view of the components shown in FIG. 1 ;
- FIG. 5 is a side view of components of one embodiment of a surgical system in accordance with the principles of the present disclosure disposed with vertebrae;
- FIG. 6 is a side view of the components and vertebrae shown in FIG. 5 .
- the exemplary embodiments of the surgical system and related methods of use disclosed are discussed in terms of medical devices for the treatment of musculoskeletal disorders and more particularly, in terms of a surgical system including a spinal implant and a method for treating a spine.
- the systems and methods of the present disclosure are employed with a spinal joint fusion, for example, with a cervical, thoracic, lumbar and/or sacral region of a spine.
- the spinal implant includes an interbody device, a plate, spinal rods and/or bone fasteners.
- the present system comprises a spinal implant including at least one pedicle subtraction osteotomy (PSO) implant for use in creating and maintaining a more lordotic angle in a lumbar spine following removal of posterior bony structures of the spine.
- PSO pedicle subtraction osteotomy
- the present system comprises a spinal implant including a hinged PSO implant. In some embodiments, the present system comprises a spinal implant designed for use during a PSO procedure. In some embodiments, the present system comprises a spinal implant including a stabilizing implant that provides a variable, hinged fulcrum for restoring lordosis and height to an affected and/or selected vertebrae. In some embodiments, the present system comprises a spinal implant including a substantial bone graft pocket and can be inserted laterally, or through a posterior lumbar interbody fusion (PLIF), transforaminal lumbar interbody fusion (TLIF) and anterior lumbar interbody fusion (ALIF) approaches. In some embodiments, the present system comprises a spinal implant that can be used with an inserter attached to either end, which may include a threaded hole and inserter prong notches on each lateral end for added control.
- PLIF posterior lumbar interbody fusion
- TLIF transforaminal lumbar interbody fusion
- ALIF anterior
- Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment. It is also understood that all spatial references, such as, for example, horizontal, vertical, top, upper, lower, bottom, left and right, are for illustrative purposes only and can be varied within the scope of the disclosure. For example, the references “upper” and “lower” are relative and used only in the context to the other, and are not necessarily “superior” and “inferior”.
- treating or “treatment” of a disease or condition refers to performing a procedure that may include administering one or more drugs to a patient (human, normal or otherwise or other mammal), employing implantable devices, and/or employing instruments that treat the disease, such as, for example, micro discectomy instruments used to remove portions bulging or herniated discs and/or bone spurs, in an effort to alleviate signs or symptoms of the disease or condition. Alleviation can occur prior to signs or symptoms of the disease or condition appearing, as well as after their appearance.
- treating or treatment includes preventing or prevention of disease or undesirable condition (e.g., preventing the disease from occurring in a patient, who may be predisposed to the disease but has not yet been diagnosed as having it).
- treating or treatment does not require complete alleviation of signs or symptoms, does not require a cure, and specifically includes procedures that have only a marginal effect on the patient.
- Treatment can include inhibiting the disease, e.g., arresting its development, or relieving the disease, e.g., causing regression of the disease.
- treatment can include reducing acute or chronic inflammation; alleviating pain and mitigating and inducing re-growth of new ligament, bone and other tissues; as an adjunct in surgery; and/or any repair procedure.
- tissue includes soft tissue, muscle, ligaments, tendons, cartilage and/or bone unless specifically referred to otherwise.
- FIGS. 1-4 there are illustrated components of a surgical system, such as, for example, a spinal implant system 10 .
- the components of spinal implant system 10 can be fabricated from biologically acceptable materials suitable for medical applications, including metals, synthetic polymers, ceramics and bone material and/or their composites.
- the components of spinal implant system 10 individually or collectively, can be fabricated from materials such as stainless steel alloys, commercially pure titanium, titanium alloys, Grade 5 titanium, super-elastic titanium alloys, cobalt-chrome alloys, stainless steel alloys, superelastic metallic alloys (e.g., Nitinol, super elasto-plastic metals, such as GUM METAL® manufactured by Toyota Material Incorporated of Japan), ceramics and composites thereof such as calcium phosphate (e.g., SKELITETM manufactured by Biologix Inc.), thermoplastics such as polyaryletherketone (PAEK) including polyetheretherketone (PEEK), polyetherketoneketone (PEKK) and polyetherketone (PEK), carbon-PEEK composites, PEEK-BaSO 4 polymeric rubbers, polyethylene ter
- Various components of spinal implant system 10 may have material composites, including the above materials, to achieve various desired characteristics such as strength, rigidity, elasticity, compliance, biomechanical performance, durability and radiolucency or imaging preference.
- the components of spinal implant system 10 individually or collectively, may also be fabricated from a heterogeneous material such as a combination of two or more of the above-described materials.
- the components of spinal implant system 10 may be monolithically formed, integrally connected or include fastening elements and/or instruments, as described herein.
- a spinal implant, as described herein may be formed substantially of a biocompatible metal, such as titanium and selectively coated with a bone-growth promoting material, such as HA.
- a spinal implant as described herein, may be formed substantially of a biocompatible polymer, such as PEEK, and selectively coated with a biocompatible metal, such as titanium, or a bone-growth promoting material, such as HA.
- a biocompatible metal such as titanium
- a bone-growth promoting material such as HA.
- titanium may be plasma sprayed onto surfaces of the spinal implant to modify a radiographic signature of the spinal implant and/or improve bony ongrowth to the spinal implant by application of a porous or semi-porous coating of titanium.
- Spinal implant system 10 may be employed, for example, with minimally invasive procedures, including percutaneous techniques, mini-open surgical techniques and/or open surgical techniques to deliver and introduce instrumentation and/or implants, such as, for example, an interbody implant, at a surgical site within a subject body of a patient, which includes, for example, a spine.
- the implant can include spinal constructs including one or more bone fasteners, spinal rods, connectors and/or plates.
- various components of spinal implant system 10 may be utilized in open or traditional spinal surgical techniques.
- Interbody implant 12 extends between an anterior surface A and a posterior surface P.
- Anterior surface A is configured to face an anterior side of a body and be disposed adjacent an anterior portion of vertebrae, such as, for example, an anterior portion A 1 of vertebrae V ( FIG. 5 ).
- Posterior surface P is configured to face a posterior side of the body and be disposed adjacent a posterior portion of vertebrae V, such as, for example, a posterior portion P 1 ( FIG. 5 ).
- Interbody implant 12 includes a member 14 and a member 16 .
- Member 14 defines an axis X 1 , as shown in FIG. 3 .
- Member 14 includes a vertebral engaging surface 18 and a surface 20 .
- surface 18 may be rough, textured, porous, semi-porous, dimpled, knurled, toothed, grooved and/or polished.
- the vertebral tissue may include intervertebral tissue, endplate surfaces and/or cortical bone.
- Surface 18 includes tissue penetrating members, such as, for example, a plurality of teeth 22 disposed along engaging surface 18 .
- teeth 22 may have various configurations, for example, round, oval, rectangular, polygonal, irregular, tapered, offset, staggered, uniform and non-uniform.
- Member 14 includes a flange 30 that defines an opening 32 .
- Opening 32 is configured for disposal of a pin 34 configured to facilitate rotation of member 14 relative to member 16 , as described herein.
- Opening 32 is configured for alignment and disposal with a channel 70 of member 16 , as described herein.
- the surface of member 16 that defines channel 70 includes a flange 72 defining an opening that is aligned with opening 32 and configured for disposal of pin 34 to facilitate rotation of member 14 relative to member 16 , as described herein.
- Member 14 includes a flange 40 , disposed with an opposing side of member 14 and relative to flange 30 , which includes an opening 42 .
- Opening 42 is configured for disposal of a pin 44 , configured to facilitate rotation of member 14 relative to member 16 , as described herein.
- Opening 42 is configured for alignment and disposal with a channel 78 of member 16 , as described herein.
- the surface of member 16 that defines channel 78 includes a flange 76 defining an opening that is aligned with opening 42 and configured for disposal of pin 44 to facilitate rotation of member 14 relative to member 16 , as described herein.
- Member 16 defines an axis X 2 .
- Member 16 includes a vertebral engaging surface 60 and a surface 62 .
- surface 60 may be rough, textured, porous, semi-porous, dimpled, knurled, toothed, grooved and/or polished.
- surface 60 includes tissue penetrating members, such as, for example, a plurality of teeth 64 disposed along engaging surface 60 .
- teeth 64 may have various configurations, for example, round, oval, rectangular, polygonal, irregular, tapered, offset, staggered, uniform and non-uniform.
- Interbody implant 12 includes an opening 80 , which is defined by the inner surfaces of members 14 , 16 , configured to receive an agent, which may include bone graft (not shown) and/or other materials, as described herein, for employment in a fixation or fusion treatment.
- member 14 includes a surface 82 that defines a cavity 84 and member 16 includes a surface 86 that defines a cavity 88 .
- Cavities 84 , 88 form opening 80 that is configured to extend between surface 18 and surface 60 .
- the agent is pre-packed.
- the agent is packed into opening 80 after interbody implant 12 is disposed with vertebrae.
- the cross-sectional geometry of members 14 , 16 may have various configurations, such as, for example, round, oval, oblong, triangular, polygonal having planar or arcuate side portions, irregular, uniform, non-uniform, consistent, variable, horseshoe shape, U-shape or kidney bean shape.
- opening 80 can be disposed at various positions along a periphery of interbody implant 12 .
- opening 80 is positioned with interbody implant 12 such that opening 80 can be post packed with bone graft from a trajectory that interbody implant 12 was implanted.
- interbody implant 12 is implanted from a lateral approach and opening 80 is disposed with a lateral side of interbody implant 12 .
- Interbody implant 12 includes a female mating portion 90 configured for engagement with surgical instrument, such as, for example, an inserter (not shown).
- Surface 20 defines a cavity 92 and surface 62 defines a cavity 94 .
- Cavities 92 , 94 define female mating portion 90 configured for engagement with a male portion of the inserter.
- surface 20 defines a second cavity 92 ′ and surface 62 defines a second cavity 94 ′.
- Cavities 92 ′, 94 ′ define a second female mating portion 96 configured for engagement with the male engagement portion of the inserter.
- mating portion 90 is disposed at an angle, such as, for example, an angle of 45 degrees relative to mating portion 96 to facilitate insertion, delivery and/or positioning of interbody implant 12 adjacent to a surgical site, which may include the spine.
- interbody implant 12 is disposed with tissue, such as, for example, vertebrae such that surfaces 18 , 60 engage vertebral tissue. In some embodiments, surfaces 18 , 60 engage vertebral tissue and provide a fulcrum between the vertebral tissue surfaces.
- surfaces 18 , 60 engage vertebral tissue and passively react to forces applied to surfaces 18 , 60 by the vertebral tissue such that surface 18 /member 14 rotate or pivot relative to surface 60 /member 16 between a first angular orientation and a second angular orientation.
- the second angular orientation of surface 18 /member 14 relative to surface 60 /member 16 corresponds to a derotated, aligned, corrected and/or treated manipulation of the vertebral tissue.
- angle ⁇ may be disposed in a range of 0-45 degrees.
- interbody implant 12 includes a hinged fulcrum configuration including variable surface 18 /member 14 , surface 60 /member 16 to provide a stabilizing implant that restores lordosis and height to affected and/or selected vertebrae.
- member 14 is rotatable and/or pivotable relative to member 16 in an anterior/posterior plane such that interbody implant 12 is configured to provide for lordosis correction of vertebrae.
- member 14 is rotatable and/or pivotable relative to member 16 in a medial/lateral plane such that interbody implant 12 is configured to provide for coronal correction of vertebrae.
- member 14 is rotatable and/or pivotable relative to member 16 anteriorly such that interbody implant 12 is configured to provide for kyphotic correction in a thoracic spine.
- member 14 is rotatable and/or pivotable relative to member 16 between a first closed configuration, as shown in FIG. 3 , such that members 14 , 16 are disposed in flush, contacting engagement adjacent anterior portion A of interbody implant 12 and angle ⁇ is 0 degrees, and a second open configuration such that members 14 , 16 are spaced apart adjacent anterior portion A and angle ⁇ is in a range of 0-45 degrees corresponding to a derotated, aligned, corrected and/or treated manipulation of the vertebral tissue.
- interbody implant 12 is fixed in the second angular orientation via curing of bone graft.
- interbody implant 12 is fixed in the second angular orientation via a locking element disposed with the flanges of members 14 , 16 . In some embodiments, interbody implant 12 is fixed in the second angular orientation via a spring element and/or resilient biasing element engaged with members 14 , 16 . In some embodiments, members 14 , 16 are relatively rotatable and/or pivotable to an open configuration such that a gap is defined between members 14 , 16 and interbody implant 12 includes a cover disposed adjacent the gap to prevent graft material from advancing past an anterior face of interbody implant 12 during a post packing procedure.
- spinal implant system 10 In assembly, operation and use, spinal implant system 10 , similar to the systems and methods described herein, is employed during a surgical procedure, such as, for example, a PSO, a vertebral column resection (VCR) or other correction treatment to treat, for example, scoliosis and/or kyphosis of a spine.
- a surgical procedure such as, for example, a PSO, a vertebral column resection (VCR) or other correction treatment to treat, for example, scoliosis and/or kyphosis of a spine.
- one or all of the components of spinal implant system 10 can be delivered or implanted as a pre-assembled device or can be assembled in-situ.
- one or all of the components of spinal implant system 10 may be completely or partially revised, removed or replaced.
- spinal implant system 10 can be used in any existing surgical method or technique including open surgery, mini-open surgery, minimally invasive surgery and percutaneous surgical implantation, whereby a section of vertebrae V including vertebra V 1 -V 3 are accessed through a mini-incision, or sleeve that provides a protected passageway to the area.
- the particular surgical procedure can be performed for treating the spine disorder.
- posterior bony structure is removed from vertebrae V.
- posterior bony structure such as, for example, pedicle tissue is removed as part of a PSO procedure.
- spinal implant system 10 is employed with a Grade 3 PSO procedure. In some embodiments, spinal implant system 10 is employed with a Grade 4 PSO procedure.
- a cutting instrument (not shown) creates a surgical pathway for implantation of components of spinal implant system 10 .
- a preparation instrument (not shown) can be employed to prepare tissue surfaces VS 1 , VS 2 of vertebrae V, as well as for aspiration and irrigation of a surgical region.
- a portion of vertebra V 2 and intervertebral disc tissue disposed between vertebrae V 1 , V 2 is removed to define a vertebral space VS including the space between vertebral surfaces VS 1 , VS 2 , and vertebra V 1 remains intact, as shown in FIG. 5 .
- vertebral space VS can include posterior portions of the spine, such as, for example, pedicles, laminae and/or spinous process.
- a wedge portion of bone and/or other tissue is removed from a selected vertebra and adjacent intervertebral disc tissue remains intact.
- pilot holes are made in selected vertebra of vertebrae V for receiving fixation elements, such as, for example, bone fasteners. Each of the bone fasteners is inserted or otherwise engaged with a particular vertebra.
- spinal constructs and rods are employed as provisional and/or working rods to support vertebrae V during a corrective procedure.
- spinal implant system 10 may include one or a plurality of the spinal constructs. In some embodiments, the plurality of spinal constructs may be disposed in various alternate orientations, such as, for example, side by side, parallel, transverse and/or other angular orientations such as acute or obtuse, co-axial and/or may be offset or staggered.
- the plurality of spinal constructs may provide a template configuration for permanently implantable spinal rods, such as, implantable, final, permanent, removable, non-removable, bio-absorbable, resorbable and/or bio-degradable, and/or comprise permanently implantable spinal rods.
- An inserter is connected with posterior surface P to engage female engagement portion 90 and/or female engagement portion 96 .
- the inserter delivers interbody implant 12 through the incision along the surgical pathway adjacent to the surgical site for implantation with vertebral space VS, as shown in FIG. 5 .
- Anterior surface A of interbody implant 12 faces an anterior side of vertebrae V adjacent anterior portion A 1 and posterior surface P faces a posterior side of vertebrae V adjacent posterior portion P 1 .
- the inserter includes image guidance and/or surgical navigation to monitor, maintain, adjust and/or confirm disposal, delivery and/or alignment of the components of spinal implant system 10 , such as, for example, interbody implant 12 along a surgical pathway and/or relative to vertebrae V.
- Interbody implant 12 is disposed in a closed configuration, as shown in FIGS. 3 and 5 , such that members 14 , 16 are disposed in flush, contacting engagement adjacent anterior portion A of interbody implant 12 and angle ⁇ is 0 degrees, similar to that described herein.
- the inserter delivers interbody implant 12 to the surgical site and vertebral space VS between vertebral surfaces VS 1 , VS 2 such that surface 18 is disposed in a cephalad orientation of the body and surface 60 is disposed in a caudal orientation of the body.
- Interbody implant 12 is inserted with vertebral space VS such that teeth 22 , 64 translate along vertebral surfaces VS 1 , VS 2 for engagement of surfaces 18 , 60 with the soft tissues, bone and/or fluids of vertebral surfaces VS 1 , VS 2 .
- Vertebrae V is derotated, aligned, corrected and/or treated via manipulation in connection with the PSO procedure.
- the posterior aspects of vertebrae V 1 , V 2 are collapsed and/or compressed to introduce a lordotic curve to vertebrae V.
- Members 14 , 16 passively react to forces applied to surfaces 18 , 60 by vertebral surfaces VS 1 , VS 2 such that surface 18 /member 14 rotate or pivot relative to surface 60 /member 16 to an open configuration, as shown in FIGS. 4 and 6 , such that members 14 , 16 are spaced apart adjacent anterior portion A and angle ⁇ is in a range of 0-45 degrees, similar to that described herein, corresponding to the PSO procedure and manipulation of vertebrae V.
- Interbody implant 12 engages vertebral surfaces VS 1 , VS 2 in connection with the orientation of manipulated vertebrae V to provide a hinged fulcrum configuration therebetween and a stabilizing construct that restores lordosis and height to vertebrae V including affected vertebral levels V 1 -V 3 .
- spinal implant system 10 Upon completion of a procedure, as described herein, the surgical instruments, assemblies and non-implanted components of spinal implant system 10 are removed and the incision(s) are closed.
- One or more of the components of spinal implant system 10 can be made of radiolucent materials such as polymers. Radiopaque markers may be included for identification under x-ray, fluoroscopy, CT or other imaging techniques.
- the use of surgical navigation, microsurgical and image guided technologies may be employed to access, view and repair spinal deterioration or damage, with the aid of spinal implant system 10 .
- spinal implant system 10 may include one or a plurality of plates, connectors and/or bone fasteners for use with a single vertebral level or a plurality of vertebral levels.
- spinal implant system 10 includes an agent, which may be disposed, packed, coated or layered within, on or about the components and/or surfaces of spinal implant system 10 .
- the agent may include bone growth promoting material, such as, for example, bone graft to enhance fixation of the components and/or surfaces of spinal implant system 10 with vertebrae.
- the agent may include one or a plurality of therapeutic agents and/or pharmacological agents for release, including sustained release, to treat, for example, pain, inflammation and degeneration.
- the components of spinal implant system 10 may be employed to treat progressive idiopathic scoliosis with or without sagittal deformity in either infantile or juvenile patients, including but not limited to pre-pubescent children, adolescents from 10-12 years old with continued growth potential, and/or older children whose growth spurt is late or who otherwise retain growth potential.
- the components of spinal implant system 10 and related methods of use may be employed to prevent or minimize curve progression in individuals of various ages.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Physical Education & Sports Medicine (AREA)
Abstract
Description
- This application claims the benefits of U.S. Provisional Patent Application No. 62/047,986 filed Sep. 9, 2014, the contents of which being hereby incorporated in its entirety by reference.
- The present disclosure generally relates to medical devices for the treatment of musculoskeletal disorders, and more particularly to a surgical system and method for treating a spine.
- Spinal pathologies and disorders such as scoliosis and other curvature abnormalities, kyphosis, degenerative disc disease, disc herniation, osteoporosis, spondylolisthesis, stenosis, tumor, and fracture may result from factors including trauma, disease and degenerative conditions caused by injury and aging. Spinal disorders typically result in symptoms including deformity, pain, nerve damage, and partial or complete loss of mobility.
- Non-surgical treatments, such as medication, rehabilitation and exercise can be effective, however, may fail to relieve the symptoms associated with these disorders. Surgical treatment of these spinal disorders includes fusion, fixation, correction, discectomy, laminectomy and implantable prosthetics. As part of these surgical treatments, spinal constructs, such as, for example, bone fasteners, spinal rods and interbody devices can be used to provide stability to a treated region. For example, during surgical treatment, interbody implants and spinal constructs can be delivered to a surgical site for fixation with bone to immobilize a joint. This disclosure describes an improvement over these prior art technologies.
- In one embodiment, a spinal implant comprises a body including a first vertebral engaging surface and a second vertebral engaging surface. The first vertebral engaging surface is rotatable relative to the second vertebral engaging surface. In some embodiments, systems and methods are provided.
- The present disclosure will become more readily apparent from the specific description accompanied by the following drawings, in which:
-
FIG. 1 is a perspective view of components of one embodiment of a system in accordance with the principles of the present disclosure; -
FIG. 2 is a side view of the components shown inFIG. 1 ; -
FIG. 3 is a side view of the components shown inFIG. 1 ; -
FIG. 4 is a side view of the components shown inFIG. 1 ; -
FIG. 5 is a side view of components of one embodiment of a surgical system in accordance with the principles of the present disclosure disposed with vertebrae; and -
FIG. 6 is a side view of the components and vertebrae shown inFIG. 5 . - The exemplary embodiments of the surgical system and related methods of use disclosed are discussed in terms of medical devices for the treatment of musculoskeletal disorders and more particularly, in terms of a surgical system including a spinal implant and a method for treating a spine. In one embodiment, the systems and methods of the present disclosure are employed with a spinal joint fusion, for example, with a cervical, thoracic, lumbar and/or sacral region of a spine. In one embodiment, the spinal implant includes an interbody device, a plate, spinal rods and/or bone fasteners.
- In some embodiments, the present system comprises a spinal implant including at least one pedicle subtraction osteotomy (PSO) implant for use in creating and maintaining a more lordotic angle in a lumbar spine following removal of posterior bony structures of the spine.
- In some embodiments, the present system comprises a spinal implant including a hinged PSO implant. In some embodiments, the present system comprises a spinal implant designed for use during a PSO procedure. In some embodiments, the present system comprises a spinal implant including a stabilizing implant that provides a variable, hinged fulcrum for restoring lordosis and height to an affected and/or selected vertebrae. In some embodiments, the present system comprises a spinal implant including a substantial bone graft pocket and can be inserted laterally, or through a posterior lumbar interbody fusion (PLIF), transforaminal lumbar interbody fusion (TLIF) and anterior lumbar interbody fusion (ALIF) approaches. In some embodiments, the present system comprises a spinal implant that can be used with an inserter attached to either end, which may include a threaded hole and inserter prong notches on each lateral end for added control.
- The present disclosure may be understood more readily by reference to the following detailed description of the embodiments taken in connection with the accompanying drawing figures, which form a part of this disclosure. It is to be understood that this application is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting. Also, in some embodiments, as used in the specification and including the appended claims, the singular forms “a,” “an,” and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment. It is also understood that all spatial references, such as, for example, horizontal, vertical, top, upper, lower, bottom, left and right, are for illustrative purposes only and can be varied within the scope of the disclosure. For example, the references “upper” and “lower” are relative and used only in the context to the other, and are not necessarily “superior” and “inferior”.
- As used in the specification and including the appended claims, “treating” or “treatment” of a disease or condition refers to performing a procedure that may include administering one or more drugs to a patient (human, normal or otherwise or other mammal), employing implantable devices, and/or employing instruments that treat the disease, such as, for example, micro discectomy instruments used to remove portions bulging or herniated discs and/or bone spurs, in an effort to alleviate signs or symptoms of the disease or condition. Alleviation can occur prior to signs or symptoms of the disease or condition appearing, as well as after their appearance. Thus, treating or treatment includes preventing or prevention of disease or undesirable condition (e.g., preventing the disease from occurring in a patient, who may be predisposed to the disease but has not yet been diagnosed as having it). In addition, treating or treatment does not require complete alleviation of signs or symptoms, does not require a cure, and specifically includes procedures that have only a marginal effect on the patient. Treatment can include inhibiting the disease, e.g., arresting its development, or relieving the disease, e.g., causing regression of the disease. For example, treatment can include reducing acute or chronic inflammation; alleviating pain and mitigating and inducing re-growth of new ligament, bone and other tissues; as an adjunct in surgery; and/or any repair procedure. Also, as used in the specification and including the appended claims, the term “tissue” includes soft tissue, muscle, ligaments, tendons, cartilage and/or bone unless specifically referred to otherwise.
- The following discussion includes a description of a surgical system and related methods of employing the surgical system in accordance with the principles of the present disclosure. Alternate embodiments are also disclosed. Reference is made in detail to the exemplary embodiments of the present disclosure, which are illustrated in the accompanying figures. Turning to
FIGS. 1-4 , there are illustrated components of a surgical system, such as, for example, aspinal implant system 10. - The components of
spinal implant system 10 can be fabricated from biologically acceptable materials suitable for medical applications, including metals, synthetic polymers, ceramics and bone material and/or their composites. For example, the components ofspinal implant system 10, individually or collectively, can be fabricated from materials such as stainless steel alloys, commercially pure titanium, titanium alloys, Grade 5 titanium, super-elastic titanium alloys, cobalt-chrome alloys, stainless steel alloys, superelastic metallic alloys (e.g., Nitinol, super elasto-plastic metals, such as GUM METAL® manufactured by Toyota Material Incorporated of Japan), ceramics and composites thereof such as calcium phosphate (e.g., SKELITE™ manufactured by Biologix Inc.), thermoplastics such as polyaryletherketone (PAEK) including polyetheretherketone (PEEK), polyetherketoneketone (PEKK) and polyetherketone (PEK), carbon-PEEK composites, PEEK-BaSO4 polymeric rubbers, polyethylene terephthalate (PET), fabric, silicone, polyurethane, silicone-polyurethane copolymers, polymeric rubbers, polyolefin rubbers, hydrogels, semi-rigid and rigid materials, elastomers, rubbers, thermoplastic elastomers, thermoset elastomers, elastomeric composites, rigid polymers including polyphenylene, polyamide, polyimide, polyetherimide, polyethylene, epoxy, bone material including autograft, allograft, xenograft or transgenic cortical and/or corticocancellous bone, and tissue growth or differentiation factors, partially resorbable materials, such as, for example, composites of metals and calcium-based ceramics, composites of PEEK and calcium based ceramics, composites of PEEK with resorbable polymers, totally resorbable materials, such as, for example, calcium based ceramics such as calcium phosphate such as hydroxyapatite (HA), corraline HA, biphasic calcium phosphate, tricalcium phosphate, or fluorapatite, tri-calcium phosphate (TCP), HA-TCP, calcium sulfate, or other resorbable polymers such as polyaetide, polyglycolide, polytyrosine carbonate, polycaroplaetohe and their combinations, biocompatible ceramics, mineralized collagen, bioactive glasses, porous metals, bone particles, bone fibers, morselized bone chips, bone morphogenetic proteins (BMP), such as BMP-2, BMP-4, BMP-7, rhBMP-2, or rhBMP-7, demineralized bone matrix (DBM), transforming growth factors (TGF, e.g., TGF-β), osteoblast cells, growth and differentiation factor (GDF), insulin-like growth factor 1, platelet-derived growth factor, fibroblast growth factor, or any combination thereof. - Various components of
spinal implant system 10 may have material composites, including the above materials, to achieve various desired characteristics such as strength, rigidity, elasticity, compliance, biomechanical performance, durability and radiolucency or imaging preference. The components ofspinal implant system 10, individually or collectively, may also be fabricated from a heterogeneous material such as a combination of two or more of the above-described materials. The components ofspinal implant system 10 may be monolithically formed, integrally connected or include fastening elements and/or instruments, as described herein. In one embodiment, a spinal implant, as described herein, may be formed substantially of a biocompatible metal, such as titanium and selectively coated with a bone-growth promoting material, such as HA. In one embodiment, a spinal implant, as described herein, may be formed substantially of a biocompatible polymer, such as PEEK, and selectively coated with a biocompatible metal, such as titanium, or a bone-growth promoting material, such as HA. In some embodiments, titanium may be plasma sprayed onto surfaces of the spinal implant to modify a radiographic signature of the spinal implant and/or improve bony ongrowth to the spinal implant by application of a porous or semi-porous coating of titanium. -
Spinal implant system 10 may be employed, for example, with minimally invasive procedures, including percutaneous techniques, mini-open surgical techniques and/or open surgical techniques to deliver and introduce instrumentation and/or implants, such as, for example, an interbody implant, at a surgical site within a subject body of a patient, which includes, for example, a spine. In some embodiments, the implant can include spinal constructs including one or more bone fasteners, spinal rods, connectors and/or plates. In some embodiments, various components ofspinal implant system 10 may be utilized in open or traditional spinal surgical techniques. -
Spinal implant system 10 includes aninterbody implant 12.Interbody implant 12 extends between an anterior surface A and a posterior surface P. Anterior surface A is configured to face an anterior side of a body and be disposed adjacent an anterior portion of vertebrae, such as, for example, an anterior portion A1 of vertebrae V (FIG. 5 ). Posterior surface P is configured to face a posterior side of the body and be disposed adjacent a posterior portion of vertebrae V, such as, for example, a posterior portion P1 (FIG. 5 ). -
Interbody implant 12 includes amember 14 and amember 16.Member 14 defines an axis X1, as shown inFIG. 3 .Member 14 includes a vertebral engagingsurface 18 and asurface 20. In some embodiments,surface 18 may be rough, textured, porous, semi-porous, dimpled, knurled, toothed, grooved and/or polished. In some embodiments, the vertebral tissue may include intervertebral tissue, endplate surfaces and/or cortical bone.Surface 18 includes tissue penetrating members, such as, for example, a plurality ofteeth 22 disposed along engagingsurface 18. In some embodiments,teeth 22 may have various configurations, for example, round, oval, rectangular, polygonal, irregular, tapered, offset, staggered, uniform and non-uniform. -
Member 14 includes aflange 30 that defines anopening 32.Opening 32 is configured for disposal of apin 34 configured to facilitate rotation ofmember 14 relative tomember 16, as described herein.Opening 32 is configured for alignment and disposal with achannel 70 ofmember 16, as described herein. In some embodiments, the surface ofmember 16 that defineschannel 70 includes aflange 72 defining an opening that is aligned with opening 32 and configured for disposal ofpin 34 to facilitate rotation ofmember 14 relative tomember 16, as described herein. -
Member 14 includes aflange 40, disposed with an opposing side ofmember 14 and relative to flange 30, which includes anopening 42.Opening 42 is configured for disposal of apin 44, configured to facilitate rotation ofmember 14 relative tomember 16, as described herein.Opening 42 is configured for alignment and disposal with achannel 78 ofmember 16, as described herein. In some embodiments, the surface ofmember 16 that defineschannel 78 includes aflange 76 defining an opening that is aligned with opening 42 and configured for disposal ofpin 44 to facilitate rotation ofmember 14 relative tomember 16, as described herein. -
Member 16 defines an axis X2.Member 16 includes a vertebral engagingsurface 60 and asurface 62. In some embodiments,surface 60 may be rough, textured, porous, semi-porous, dimpled, knurled, toothed, grooved and/or polished. In some embodiments,surface 60 includes tissue penetrating members, such as, for example, a plurality ofteeth 64 disposed along engagingsurface 60. In some embodiments,teeth 64 may have various configurations, for example, round, oval, rectangular, polygonal, irregular, tapered, offset, staggered, uniform and non-uniform. -
Interbody implant 12 includes anopening 80, which is defined by the inner surfaces ofmembers member 14 includes asurface 82 that defines acavity 84 andmember 16 includes asurface 86 that defines acavity 88.Cavities surface 18 andsurface 60. In some embodiments, the agent is pre-packed. In some embodiments, the agent is packed intoopening 80 after interbodyimplant 12 is disposed with vertebrae. In some embodiments, the cross-sectional geometry ofmembers interbody implant 12. In some embodiments, opening 80 is positioned withinterbody implant 12 such thatopening 80 can be post packed with bone graft from a trajectory that interbodyimplant 12 was implanted. In one embodiment,interbody implant 12 is implanted from a lateral approach andopening 80 is disposed with a lateral side ofinterbody implant 12. -
Interbody implant 12 includes afemale mating portion 90 configured for engagement with surgical instrument, such as, for example, an inserter (not shown).Surface 20 defines acavity 92 andsurface 62 defines acavity 94.Cavities female mating portion 90 configured for engagement with a male portion of the inserter. In some embodiments,surface 20 defines asecond cavity 92′ andsurface 62 defines asecond cavity 94′.Cavities 92′, 94′ define a secondfemale mating portion 96 configured for engagement with the male engagement portion of the inserter. In some embodiments,mating portion 90 is disposed at an angle, such as, for example, an angle of 45 degrees relative tomating portion 96 to facilitate insertion, delivery and/or positioning ofinterbody implant 12 adjacent to a surgical site, which may include the spine. -
Member 14 is rotatable and/or pivotable relative tomember 16 aboutpins interbody implant 12 is disposed with tissue, such as, for example, vertebrae such that surfaces 18, 60 engage vertebral tissue. In some embodiments, surfaces 18, 60 engage vertebral tissue and provide a fulcrum between the vertebral tissue surfaces. In some embodiments, surfaces 18, 60 engage vertebral tissue and passively react to forces applied tosurfaces surface 18/member 14 rotate or pivot relative to surface 60/member 16 between a first angular orientation and a second angular orientation. In some embodiments, the second angular orientation ofsurface 18/member 14 relative to surface 60/member 16 corresponds to a derotated, aligned, corrected and/or treated manipulation of the vertebral tissue. In some embodiments, angle β may be disposed in a range of 0-45 degrees. In some embodiments,interbody implant 12 includes a hinged fulcrum configuration includingvariable surface 18/member 14,surface 60/member 16 to provide a stabilizing implant that restores lordosis and height to affected and/or selected vertebrae. In some embodiments,member 14 is rotatable and/or pivotable relative tomember 16 in an anterior/posterior plane such thatinterbody implant 12 is configured to provide for lordosis correction of vertebrae. In some embodiments,member 14 is rotatable and/or pivotable relative tomember 16 in a medial/lateral plane such thatinterbody implant 12 is configured to provide for coronal correction of vertebrae. In some embodiments,member 14 is rotatable and/or pivotable relative tomember 16 anteriorly such thatinterbody implant 12 is configured to provide for kyphotic correction in a thoracic spine. - In some embodiments,
member 14 is rotatable and/or pivotable relative tomember 16 between a first closed configuration, as shown inFIG. 3 , such thatmembers interbody implant 12 and angle β is 0 degrees, and a second open configuration such thatmembers interbody implant 12 is fixed in the second angular orientation via curing of bone graft. In some embodiments,interbody implant 12 is fixed in the second angular orientation via a locking element disposed with the flanges ofmembers interbody implant 12 is fixed in the second angular orientation via a spring element and/or resilient biasing element engaged withmembers members members interbody implant 12 includes a cover disposed adjacent the gap to prevent graft material from advancing past an anterior face ofinterbody implant 12 during a post packing procedure. - In assembly, operation and use,
spinal implant system 10, similar to the systems and methods described herein, is employed during a surgical procedure, such as, for example, a PSO, a vertebral column resection (VCR) or other correction treatment to treat, for example, scoliosis and/or kyphosis of a spine. In some embodiments, one or all of the components ofspinal implant system 10 can be delivered or implanted as a pre-assembled device or can be assembled in-situ. In some embodiments, one or all of the components ofspinal implant system 10 may be completely or partially revised, removed or replaced. - To treat an affected section of vertebrae V, as shown in
FIG. 5 , a medical practitioner obtains access to a surgical site including vertebra V1, V2, V3. In some embodiments,spinal implant system 10 can be used in any existing surgical method or technique including open surgery, mini-open surgery, minimally invasive surgery and percutaneous surgical implantation, whereby a section of vertebrae V including vertebra V1-V3 are accessed through a mini-incision, or sleeve that provides a protected passageway to the area. Once access to the surgical site is obtained, the particular surgical procedure can be performed for treating the spine disorder. In some embodiments, posterior bony structure is removed from vertebrae V. In some embodiments, posterior bony structure, such as, for example, pedicle tissue is removed as part of a PSO procedure. In some embodiments,spinal implant system 10 is employed with a Grade 3 PSO procedure. In some embodiments,spinal implant system 10 is employed with a Grade 4 PSO procedure. - An incision is made in the body of a patient and a cutting instrument (not shown) creates a surgical pathway for implantation of components of
spinal implant system 10. A preparation instrument (not shown) can be employed to prepare tissue surfaces VS1, VS2 of vertebrae V, as well as for aspiration and irrigation of a surgical region. In some embodiments, a portion of vertebra V2 and intervertebral disc tissue disposed between vertebrae V1, V2 is removed to define a vertebral space VS including the space between vertebral surfaces VS1, VS2, and vertebra V1 remains intact, as shown inFIG. 5 . In some embodiments, vertebral space VS can include posterior portions of the spine, such as, for example, pedicles, laminae and/or spinous process. In some embodiments, a wedge portion of bone and/or other tissue is removed from a selected vertebra and adjacent intervertebral disc tissue remains intact. - In some embodiments, pilot holes are made in selected vertebra of vertebrae V for receiving fixation elements, such as, for example, bone fasteners. Each of the bone fasteners is inserted or otherwise engaged with a particular vertebra. In some embodiments, spinal constructs and rods are employed as provisional and/or working rods to support vertebrae V during a corrective procedure. In some embodiments,
spinal implant system 10 may include one or a plurality of the spinal constructs. In some embodiments, the plurality of spinal constructs may be disposed in various alternate orientations, such as, for example, side by side, parallel, transverse and/or other angular orientations such as acute or obtuse, co-axial and/or may be offset or staggered. In some embodiments, the plurality of spinal constructs may provide a template configuration for permanently implantable spinal rods, such as, implantable, final, permanent, removable, non-removable, bio-absorbable, resorbable and/or bio-degradable, and/or comprise permanently implantable spinal rods. - An inserter is connected with posterior surface P to engage
female engagement portion 90 and/orfemale engagement portion 96. The inserter deliversinterbody implant 12 through the incision along the surgical pathway adjacent to the surgical site for implantation with vertebral space VS, as shown inFIG. 5 . Anterior surface A ofinterbody implant 12 faces an anterior side of vertebrae V adjacent anterior portion A1 and posterior surface P faces a posterior side of vertebrae V adjacent posterior portion P1. In some embodiments, the inserter includes image guidance and/or surgical navigation to monitor, maintain, adjust and/or confirm disposal, delivery and/or alignment of the components ofspinal implant system 10, such as, for example,interbody implant 12 along a surgical pathway and/or relative to vertebrae V. -
Interbody implant 12 is disposed in a closed configuration, as shown inFIGS. 3 and 5 , such thatmembers interbody implant 12 and angle β is 0 degrees, similar to that described herein. The inserter deliversinterbody implant 12 to the surgical site and vertebral space VS between vertebral surfaces VS1, VS2 such thatsurface 18 is disposed in a cephalad orientation of the body andsurface 60 is disposed in a caudal orientation of the body.Interbody implant 12 is inserted with vertebral space VS such thatteeth surfaces - Vertebrae V is derotated, aligned, corrected and/or treated via manipulation in connection with the PSO procedure. In some embodiments, the posterior aspects of vertebrae V1, V2 are collapsed and/or compressed to introduce a lordotic curve to
vertebrae V. Members surfaces surface 18/member 14 rotate or pivot relative to surface 60/member 16 to an open configuration, as shown inFIGS. 4 and 6 , such thatmembers V. Interbody implant 12 engages vertebral surfaces VS1, VS2 in connection with the orientation of manipulated vertebrae V to provide a hinged fulcrum configuration therebetween and a stabilizing construct that restores lordosis and height to vertebrae V including affected vertebral levels V1-V3. - Upon completion of a procedure, as described herein, the surgical instruments, assemblies and non-implanted components of
spinal implant system 10 are removed and the incision(s) are closed. One or more of the components ofspinal implant system 10 can be made of radiolucent materials such as polymers. Radiopaque markers may be included for identification under x-ray, fluoroscopy, CT or other imaging techniques. In some embodiments, the use of surgical navigation, microsurgical and image guided technologies may be employed to access, view and repair spinal deterioration or damage, with the aid ofspinal implant system 10. In some embodiments,spinal implant system 10 may include one or a plurality of plates, connectors and/or bone fasteners for use with a single vertebral level or a plurality of vertebral levels. - In some embodiments,
spinal implant system 10 includes an agent, which may be disposed, packed, coated or layered within, on or about the components and/or surfaces ofspinal implant system 10. In some embodiments, the agent may include bone growth promoting material, such as, for example, bone graft to enhance fixation of the components and/or surfaces ofspinal implant system 10 with vertebrae. In some embodiments, the agent may include one or a plurality of therapeutic agents and/or pharmacological agents for release, including sustained release, to treat, for example, pain, inflammation and degeneration. - In some embodiments, the components of
spinal implant system 10 may be employed to treat progressive idiopathic scoliosis with or without sagittal deformity in either infantile or juvenile patients, including but not limited to pre-pubescent children, adolescents from 10-12 years old with continued growth potential, and/or older children whose growth spurt is late or who otherwise retain growth potential. In some embodiments, the components ofspinal implant system 10 and related methods of use may be employed to prevent or minimize curve progression in individuals of various ages. - It will be understood that various modifications may be made to the embodiments disclosed herein. Therefore, the above description should not be construed as limiting, but merely as exemplification of the various embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.
Claims (22)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/522,946 US20190343656A1 (en) | 2014-09-09 | 2019-07-26 | Spinal implant system and method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462047986P | 2014-09-09 | 2014-09-09 | |
US14/835,234 US10405990B2 (en) | 2014-09-09 | 2015-08-25 | Spinal implant system and method |
US16/522,946 US20190343656A1 (en) | 2014-09-09 | 2019-07-26 | Spinal implant system and method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/835,234 Division US10405990B2 (en) | 2014-09-09 | 2015-08-25 | Spinal implant system and method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190343656A1 true US20190343656A1 (en) | 2019-11-14 |
Family
ID=55436430
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/835,234 Active 2037-07-05 US10405990B2 (en) | 2014-09-09 | 2015-08-25 | Spinal implant system and method |
US16/522,946 Abandoned US20190343656A1 (en) | 2014-09-09 | 2019-07-26 | Spinal implant system and method |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/835,234 Active 2037-07-05 US10405990B2 (en) | 2014-09-09 | 2015-08-25 | Spinal implant system and method |
Country Status (2)
Country | Link |
---|---|
US (2) | US10405990B2 (en) |
WO (1) | WO2016040125A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2906882A1 (en) | 2013-03-15 | 2014-09-18 | Revivo Medical, Llc | Intervertebral cage and method of treating vertebrae with an intervertebral cage |
US9788971B1 (en) | 2013-05-22 | 2017-10-17 | Nuvasive, Inc. | Expandable fusion implant and related methods |
US9877846B2 (en) * | 2015-01-20 | 2018-01-30 | Warsaw Orthopedic, Inc. | Spinal implant system and method |
US11234833B2 (en) | 2015-05-12 | 2022-02-01 | Nuvasive, Inc. | Expandable lordosis intervertebral implants |
EP3397212B1 (en) | 2015-12-30 | 2025-03-26 | Nuvasive, Inc. | Lordotic expandable fusion implant |
IT201600105751A1 (en) | 2016-10-20 | 2018-04-20 | Medacta Int Sa | INTERVERTEBRAL FUSION CAGE |
US10966839B2 (en) | 2017-06-30 | 2021-04-06 | Warsaw Orthopedic, Inc. | Spinal implant system and method |
US10918497B1 (en) * | 2017-10-24 | 2021-02-16 | Omnia Medical, LLC | Multi-material multi-component spinal implant |
US11766339B1 (en) | 2017-10-24 | 2023-09-26 | Omnia Medical, LLC | Multi-material multi-component spinal implant |
AU2018388574B2 (en) | 2017-12-18 | 2024-05-02 | Nuvasive, Inc. | Expandable implant device |
US10524927B2 (en) * | 2018-05-08 | 2020-01-07 | Globus Medical, Inc. | Intervertebral spinal implant |
US10966736B2 (en) | 2018-05-21 | 2021-04-06 | Warsaw Orthopedic, Inc. | Spinal implant system and methods of use |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3061080A (en) | 1961-11-06 | 1962-10-30 | Walter F Stephen | Article container |
US3315402A (en) | 1964-10-01 | 1967-04-25 | Leo J Kottas | Live bait container with improved cover |
US4328904A (en) | 1981-02-03 | 1982-05-11 | Iverson Elaine J | Spill proof container and closure |
IT8822461A0 (en) | 1988-10-28 | 1988-10-28 | Leone Marcello | SINGLE-SERVICE CONTAINER FOR DRINKS, EQUIPPED WITH A WALL OR A LID, EQUIPPED TO ALLOW THE INSERTION, THROUGH THE SAME, WITH A GOOD SEAL, OF A STRAW WITH A SUBSTANTIALLY RECTANGULAR SECTION |
US5259501A (en) | 1991-09-10 | 1993-11-09 | Mcdonald, Withers & Hughes, Inc. | Personal use syringe collecting and disposing system |
US5342365A (en) | 1993-07-19 | 1994-08-30 | Padgett Instruments, Inc. | Surgical rasp |
US5709683A (en) | 1995-12-19 | 1998-01-20 | Spine-Tech, Inc. | Interbody bone implant having conjoining stabilization features for bony fusion |
US5676990A (en) | 1996-04-29 | 1997-10-14 | Wawrzynski; David W. | Method of food article dipping and wiping in a condiment container |
US5964533A (en) | 1996-09-16 | 1999-10-12 | Lamont Limited | Hamper apparatus and methods |
US6482233B1 (en) | 1998-01-29 | 2002-11-19 | Synthes(U.S.A.) | Prosthetic interbody spacer |
US6193757B1 (en) | 1998-10-29 | 2001-02-27 | Sdgi Holdings, Inc. | Expandable intervertebral spacers |
US20010035414A1 (en) | 2000-04-26 | 2001-11-01 | Tyree Kellie E. | Disposable coverlet |
US8302798B2 (en) | 2001-09-04 | 2012-11-06 | Moss Christine K | Anti-spill container |
US6685742B1 (en) | 2002-11-12 | 2004-02-03 | Roger P. Jackson | Articulated anterior expandable spinal fusion cage system |
US6656514B1 (en) | 2002-11-13 | 2003-12-02 | Venita Tubbs | Spill-proof lid and container |
US20050252923A1 (en) | 2004-05-13 | 2005-11-17 | Woolf Mary P | Spill proof container for non-liquid materials |
US7875080B2 (en) | 2004-11-10 | 2011-01-25 | Warsaw Orthopedic, Inc. | Intervertebral spacer |
US7591388B2 (en) | 2005-07-12 | 2009-09-22 | Philip Salvatore Amormino | Spill-resistant container |
US20110153020A1 (en) * | 2009-12-17 | 2011-06-23 | Custom Spine, Inc. | Anterior Lumbar Interbody |
US8496706B2 (en) | 2010-08-02 | 2013-07-30 | Ashraf A. Ragab | Bone cage with components for controlled expansion |
US8518114B2 (en) * | 2011-04-21 | 2013-08-27 | Warsaw Orthopedic, Inc. | Expandable implant system and methods of use |
US20130110238A1 (en) | 2011-10-26 | 2013-05-02 | Warsaw Orthopedic, Inc. | Interbody implant |
US9427331B2 (en) * | 2014-07-15 | 2016-08-30 | Apifix Ltd. | Spinal cage |
-
2015
- 2015-08-25 US US14/835,234 patent/US10405990B2/en active Active
- 2015-09-03 WO PCT/US2015/048376 patent/WO2016040125A1/en active Application Filing
-
2019
- 2019-07-26 US US16/522,946 patent/US20190343656A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20160067056A1 (en) | 2016-03-10 |
WO2016040125A1 (en) | 2016-03-17 |
US10405990B2 (en) | 2019-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190343656A1 (en) | Spinal implant system and method | |
EP3174504B1 (en) | Spinal implant system | |
US9782270B2 (en) | Spinal implant system and method | |
EP3174486B1 (en) | Spinal implant | |
US9517143B2 (en) | Adaptable interbody implant and methods of use | |
US20150196400A1 (en) | Spinal implant system and method of use | |
US11141287B2 (en) | Spinal implant system and method | |
US20160374819A1 (en) | Intrabody osteotomy implant and methods of use | |
US10327914B2 (en) | Spinal implant system and method of use | |
US20240398578A1 (en) | Spinal implant system and method | |
US20160331544A1 (en) | Spinal implant system and method | |
US10117690B2 (en) | Spinal implant system and method | |
US10307187B2 (en) | Spinal implant system and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |